ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 2005–2016 of 2020 project topics
Polygenic Risk Score SaaS Platform for Precision Medicine
A cloud-based platform that calculates and interprets polygenic risk scores across multiple disease conditions using proprietary algorithms and continuously updated genetic databases. Enables healthcare providers and insurers to offer personalized risk stratification services, creating recurring subscription revenue and supporting preventive care monetization strategies.
Future Directions in Human Genetics Click to view more details →
Pharmacogenomics Testing and Drug Interaction Prediction Engine
A comprehensive commercial service that sequences relevant pharmacogenes and uses machine learning to predict adverse drug reactions and optimize medication selection for individual patients. Generates revenue through laboratory testing fees, clinical decision support subscriptions, and partnerships with pharmaceutical companies for drug development and market positioning.
Future Directions in Human Genetics Click to view more details →
Long-Read Sequencing Data Analysis Platform for Structural Variants
A proprietary software platform that processes and analyzes long-read sequencing data to detect complex structural variants, copy number variations, and repeat expansions missed by short-read technologies. Delivers value through licensing to clinical laboratories, research institutions, and diagnostic companies seeking comprehensive variant detection capabilities and improved diagnostic accuracy.
Future Directions in Human Genetics Click to view more details →
Non-Invasive Prenatal Testing Reporting and Counseling Portal
A digital platform that integrates NIPT result delivery, genetic counseling, and risk communication tools with advanced visualization for pregnant individuals and their healthcare providers. Monetizes through per-test reporting fees, counseling session coordination, and data licensing partnerships with reproductive health organizations and maternity care networks.
Future Directions in Human Genetics Click to view more details →
Rare Disease Gene Candidate Prioritization and Discovery Tool
A commercial software tool that combines whole exome/genome sequencing analysis with integrated phenotype matching, literature mining, and functional prediction to rapidly identify pathogenic variants in rare genetic disorders. Generates revenue through diagnostic laboratory partnerships, pharmaceutical company licensing for drug target identification, and per-case analysis fees from medical centers.
Future Directions in Human Genetics Click to view more details →
Clinical Grade Cancer Genomics Report Generation and Surveillance Platform
An enterprise platform that automates tumor sequencing analysis, generates clinical-grade reports with actionable mutation data, and provides ongoing surveillance for emerging treatment options and clinical trials. Delivers revenue through tumor profiling service fees, oncology center institutional licenses, and integration partnerships with electronic health record and cancer registry systems.
Future Directions in Human Genetics Click to view more details →
PRKAR1A Carney Complex Gene Testing
Characterizing PRKAR1A inactivating variants causing Carney complex for molecular diagnosis and screening for cardiac myxomas and endocrine tumors.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
VHL Syndrome Comprehensive Gene Analysis
Developing VHL gene sequencing and deletion detection for diagnosing VHL syndrome and correlating genotype with renal cell carcinoma, hemangioblastoma, and pheochromocytoma risk.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
Succinate Dehydrogenase Related Paraganglioma
Applying comprehensive SDHx gene panel testing and prioritizing SDHB for malignant paraganglioma risk assessment and intensive surveillance.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
Insulinoma Genetics and MEN1 Association
Investigating MEN1 gene mutations in apparently sporadic insulinoma patients for identifying occult MEN1 syndrome requiring surveillance.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
RET Proto-oncogene Mutation Detection SaaS Platform
A cloud-based diagnostic platform that identifies RET mutations associated with medullary thyroid carcinoma and multiple endocrine neoplasia type 2, enabling rapid clinical stratification and risk assessment. The platform generates recurring subscription revenue through clinical laboratory partnerships and enables pharmaceutical companies to identify patient cohorts for targeted therapy trials.
Genetic Basis of Rare Endocrine Tumors Click to view more details →
SDHA SDHB Genetic Screening Commercial Testing Service
A specialized genetic testing service that provides comprehensive SDH complex gene sequencing for pheochromocytoma and paraganglioma risk assessment with integrated interpretation tools. This direct-to-clinician service creates revenue through per-test pricing, insurance reimbursement, and partnerships with endocrinology networks.
Genetic Basis of Rare Endocrine Tumors Click to view more details →